KNC Laboratories Co.,Ltd. Financial Overview
KNC Laboratories Co.,Ltd.'s market cap is currently ¥8.64B. The company's EPS TTM is ¥1.59; its P/E ratio is 12.55; and it has a dividend yield of 2.97%. KNC Laboratories Co.,Ltd. is scheduled to report earnings on November 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
